01789nas a2200217   4500008004500000022001400045245003900059210003900098260001300137300000700150490000700157520123200164653002201396653003201418100001301450700001401463700001501477700001701492700001301509856004901522       2012                        Engldsh    a0268-336900aCMV encephalitis in BMT recipients0 aCMV encephalitis in BMT recipients  cFebruary  a180 v473 aReferences: 1 Reddy SM, Winston DJ, Territo MC, Schiller GJ. CMV central nervous system disease in stem-cell transplant recipients: an increasing complication of drug-resistant CMV infection and protracted immunodeficiency. Bone Marrow Transplant 2010; 45: 979-984. 2 Miller GG, Boivin G, Dummer JS, McConnell T, Becher MW, Kassim A et al. Cytomegalovirus ventriculoencephalitis in a peripheral blood stem cell transplant recipient. Clin Infect Dis 2006; 42: e26-e29. 3 Janowicz DM, Johnson RM, Gupta SK. Successful treatment of CMV ventriculitis immune reconstitution syndrome. J Neurol Neurosurg Psychiatry 2005; 76: 891-892. 4 Emery VC, Cope AV, Bowen EF, Gor D, Griffiths PD. The dynamics of human cytomegalovirus replication in vivo. J Exp Med 1999; 190: 177-182. 5 Wolf DG, Lee DJ, Spector SA. Detection of human cytomegalovirus mutations associated with ganciclovir resistance in cerebrospinal fluid in AIDS patients with central nervous system disease. Antimicrob Agents Chemother 1995; 39: 2552-2554. 6 Wolf DG, Lurrain NS, Zuckerman T, Hoffman R, Satinger J, Honigman A et al. Emergence of late cytomegalovirus central nervous system disease in hematopoietic stem cell transplant recipients. Blood 2003; 101: 463-465.10aClinical Medicine10aLife & Biomedical Sciences.1 aSarva, H1 aGraber, J1 aRemanan, R1 aRosenblum, M1 aOmuro, A  uhttps://www.notifylibrary.org/reference/1825